TJ-68
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TJ-68, covering 2025-05-01 to 2025-05-01. Get the full timeline:
Most recent: Clinical Trial Update: TJ-68 Clinical Trial in Patients With Amyotrophic Lateral Sclerosis (ALS) and Muscle Cramps [Phase 1, Phase 2]